FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019935589> ?p ?o ?g. }

• W2019935589 endingPage "87" @default.
• W2019935589 startingPage "79" @default.
• W2019935589 abstract "ObjectiveTo investigate the levels of matrix metalloproteinases (MMPs), myeloperoxidase (MPO), and tissue inhibitor of metalloproteinase-1 (TIMP-1) in tears of patients with Stevens-Johnson syndrome (SJS) and ocular cicatricial pemphigoid (OCP).DesignProspective, noninterventional cohort study.ParticipantsFour SJS patients (7 eyes), 19 OCP patients (37 eyes), and 20 healthy controls who underwent phacoemulsification (40 eyes).MethodsTear washes were collected from all patients and were analyzed for levels of MMP-2, MMP-3, MMP-7, MMP-8, MMP-9, MMP-12, MPO, and TIMP-1 using multianalyte bead-based enzyme-linked immunosorbent assays. Total MMP activity was determined using a fluorometric assay. Correlation studies were performed between the various analytes within study groups.Main Outcome MeasuresLevels of MMP-2, MMP-3, MMP-7, MMP-8, MMP-9, MMP-12, MPO, and TIMP-1 (in nanograms per microgram of protein) and total MMP activity (in relative fluorescent units per minute per microgram of protein) in tears; MMP-8–to–TIMP-1 ratio; MMP-9–to–TIMP-1 ratio; and the correlations between MMP-8 and MMP-9 and both MMP and MPO.ResultsMMP-8, MMP-9, and MPO levels were elevated significantly in SJS and OCP tears (SJS>OCP) when compared with controls. The MMP activity was highest in SJS patients, whereas OCP patients and controls showed lower and similar activities. The TIMP-1 levels were decreased in SJS and OCP patients when compared with those in controls, with levels in OCP patients reaching significance. The MMP-8–to–TIMP-1 and MMP-9–to–TIMP-1 ratios were markedly elevated in SJS and OCP tears (SJS>OCP) when compared with those of controls. Across all study groups, MMP-9 levels correlated strongly with MMP-8 and MPO levels, and MMP-8 correlated with MPO, but it did not reach significance in SJS patients. There was no relationship between MMP-7 and MPO.ConclusionsBecause MMP-8 and MPO are produced by inflammatory cells, particularly neutrophils, the correlation data indicate that they may be the common source of elevated enzymes, including MMP-9, in SJS and OCP tears. Elevated MMP-to-TIMP ratios and MMP activity suggest an imbalance in tear MMP regulation that may explain the predisposition of these patients to demonstrate corneal melting and chronic complications associated with persistent inflammation. Myeloperoxidase in tears may be a sensitive and specific marker for the quantification of ocular inflammation. To investigate the levels of matrix metalloproteinases (MMPs), myeloperoxidase (MPO), and tissue inhibitor of metalloproteinase-1 (TIMP-1) in tears of patients with Stevens-Johnson syndrome (SJS) and ocular cicatricial pemphigoid (OCP). Prospective, noninterventional cohort study. Four SJS patients (7 eyes), 19 OCP patients (37 eyes), and 20 healthy controls who underwent phacoemulsification (40 eyes). Tear washes were collected from all patients and were analyzed for levels of MMP-2, MMP-3, MMP-7, MMP-8, MMP-9, MMP-12, MPO, and TIMP-1 using multianalyte bead-based enzyme-linked immunosorbent assays. Total MMP activity was determined using a fluorometric assay. Correlation studies were performed between the various analytes within study groups. Levels of MMP-2, MMP-3, MMP-7, MMP-8, MMP-9, MMP-12, MPO, and TIMP-1 (in nanograms per microgram of protein) and total MMP activity (in relative fluorescent units per minute per microgram of protein) in tears; MMP-8–to–TIMP-1 ratio; MMP-9–to–TIMP-1 ratio; and the correlations between MMP-8 and MMP-9 and both MMP and MPO. MMP-8, MMP-9, and MPO levels were elevated significantly in SJS and OCP tears (SJS>OCP) when compared with controls. The MMP activity was highest in SJS patients, whereas OCP patients and controls showed lower and similar activities. The TIMP-1 levels were decreased in SJS and OCP patients when compared with those in controls, with levels in OCP patients reaching significance. The MMP-8–to–TIMP-1 and MMP-9–to–TIMP-1 ratios were markedly elevated in SJS and OCP tears (SJS>OCP) when compared with those of controls. Across all study groups, MMP-9 levels correlated strongly with MMP-8 and MPO levels, and MMP-8 correlated with MPO, but it did not reach significance in SJS patients. There was no relationship between MMP-7 and MPO. Because MMP-8 and MPO are produced by inflammatory cells, particularly neutrophils, the correlation data indicate that they may be the common source of elevated enzymes, including MMP-9, in SJS and OCP tears. Elevated MMP-to-TIMP ratios and MMP activity suggest an imbalance in tear MMP regulation that may explain the predisposition of these patients to demonstrate corneal melting and chronic complications associated with persistent inflammation. Myeloperoxidase in tears may be a sensitive and specific marker for the quantification of ocular inflammation." @default.
• W2019935589 created "2016-06-24" @default.
• W2019935589 creator A5028547155 @default.
• W2019935589 creator A5030299442 @default.
• W2019935589 creator A5033248906 @default.
• W2019935589 creator A5053862589 @default.
• W2019935589 creator A5060669518 @default.
• W2019935589 creator A5064160717 @default.
• W2019935589 creator A5065350279 @default.
• W2019935589 date "2014-01-01" @default.
• W2019935589 modified "2023-09-25" @default.
• W2019935589 title "Neutrophil Collagenase, Gelatinase, and Myeloperoxidase in Tears of Patients with Stevens-Johnson Syndrome and Ocular Cicatricial Pemphigoid" @default.
• W2019935589 cites W1963831154 @default.
• W2019935589 cites W1965524311 @default.
• W2019935589 cites W1972147971 @default.
• W2019935589 cites W1984483336 @default.
• W2019935589 cites W1997830990 @default.
• W2019935589 cites W2005415233 @default.
• W2019935589 cites W2015591510 @default.
• W2019935589 cites W2016720337 @default.
• W2019935589 cites W2025152777 @default.
• W2019935589 cites W2025217814 @default.
• W2019935589 cites W2028006762 @default.
• W2019935589 cites W2031298400 @default.
• W2019935589 cites W2036404921 @default.
• W2019935589 cites W2036508137 @default.
• W2019935589 cites W2039869380 @default.
• W2019935589 cites W2045319896 @default.
• W2019935589 cites W2050185652 @default.
• W2019935589 cites W2050651069 @default.
• W2019935589 cites W2051256601 @default.
• W2019935589 cites W2058320383 @default.
• W2019935589 cites W2059149560 @default.
• W2019935589 cites W2063938833 @default.
• W2019935589 cites W2068160105 @default.
• W2019935589 cites W2068400013 @default.
• W2019935589 cites W2070872710 @default.
• W2019935589 cites W2071359561 @default.
• W2019935589 cites W2075347434 @default.
• W2019935589 cites W2086684278 @default.
• W2019935589 cites W2089633474 @default.
• W2019935589 cites W2091616446 @default.
• W2019935589 cites W2113362104 @default.
• W2019935589 cites W2116927693 @default.
• W2019935589 cites W2120115448 @default.
• W2019935589 cites W2149790826 @default.
• W2019935589 cites W2154787277 @default.
• W2019935589 cites W2160871054 @default.
• W2019935589 cites W2161867368 @default.
• W2019935589 cites W2167818820 @default.
• W2019935589 cites W2315970154 @default.
• W2019935589 cites W2325454579 @default.
• W2019935589 cites W2785991938 @default.
• W2019935589 cites W64196496 @default.
• W2019935589 doi "https://doi.org/10.1016/j.ophtha.2013.06.049" @default.
• W2019935589 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3920830" @default.
• W2019935589 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23962653" @default.
• W2019935589 hasPublicationYear "2014" @default.
• W2019935589 type Work @default.
• W2019935589 sameAs 2019935589 @default.
• W2019935589 citedByCount "49" @default.
• W2019935589 countsByYear W20199355892014 @default.
• W2019935589 countsByYear W20199355892015 @default.
• W2019935589 countsByYear W20199355892016 @default.
• W2019935589 countsByYear W20199355892017 @default.
• W2019935589 countsByYear W20199355892018 @default.
• W2019935589 countsByYear W20199355892019 @default.
• W2019935589 countsByYear W20199355892020 @default.
• W2019935589 countsByYear W20199355892021 @default.
• W2019935589 countsByYear W20199355892022 @default.
• W2019935589 countsByYear W20199355892023 @default.
• W2019935589 crossrefType "journal-article" @default.
• W2019935589 hasAuthorship W2019935589A5028547155 @default.
• W2019935589 hasAuthorship W2019935589A5030299442 @default.
• W2019935589 hasAuthorship W2019935589A5033248906 @default.
• W2019935589 hasAuthorship W2019935589A5053862589 @default.
• W2019935589 hasAuthorship W2019935589A5060669518 @default.
• W2019935589 hasAuthorship W2019935589A5064160717 @default.
• W2019935589 hasAuthorship W2019935589A5065350279 @default.
• W2019935589 hasBestOaLocation W20199355892 @default.
• W2019935589 hasConcept C109523444 @default.
• W2019935589 hasConcept C126322002 @default.
• W2019935589 hasConcept C142724271 @default.
• W2019935589 hasConcept C159654299 @default.
• W2019935589 hasConcept C181199279 @default.
• W2019935589 hasConcept C185592680 @default.
• W2019935589 hasConcept C203014093 @default.
• W2019935589 hasConcept C203565725 @default.
• W2019935589 hasConcept C2776232661 @default.
• W2019935589 hasConcept C2776747403 @default.
• W2019935589 hasConcept C2776914184 @default.
• W2019935589 hasConcept C2778075117 @default.
• W2019935589 hasConcept C2778275304 @default.
• W2019935589 hasConcept C2778394429 @default.
• W2019935589 hasConcept C2779252107 @default.
• W2019935589 hasConcept C55493867 @default.
• W2019935589 hasConcept C71924100 @default.
• W2019935589 hasConcept C90924648 @default.

• next